Turn Therapeutics Inc. (TTRX) — Institutional Holders, Q2 2026
29 institutional investment managers reported a TTRX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $8.5M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
TTRX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- SteelPeak WealthNew · +249,456 sh+$1.8M
- IEQ CAPITALNew · +227,396 sh+$1.7M
- BlackRockNew · +38,591 sh+$281.7K
- DDFGAdded · +37,295 sh+$272.3K
- Aaron Wealth AdvisorsNew · +32,564 sh+$237.7K
Biggest sellers
- XTX Topco LtdSold out · -19,727 sh-$144.0K
- Hodges Capital ManagementSold out · -10,000 sh-$73.0K
- MILLENNIUM MANAGEMENTTrimmed · -9,206 sh-$67.2K
- LPL FinancialTrimmed · -3,000 sh-$21.9K
TTRX 13F holders ranked 1–29 of 29
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | SteelPeak Wealth#1 · 249,456 sh | 249,456 | $1.8M | — | New |
| 2 | IEQ CAPITAL#2 · 227,396 sh | 227,396 | $1.7M | <0.01% | New |
| 3 | DDFG#3 · 107,829 sh | 107,829 | $787.2K | — | +52.9% |
| 4 | VANGUARD CAPITAL MANAGEMENT#4 · 74,301 sh | 74,301 | $542.4K | 0.00% | +50.3% |
| 5 | Wellington Shields#5 · 65,732 sh | 65,732 | $479.8K | 0.11% | 0.0% |
| 6 | MILLENNIUM MANAGEMENT#6 · 60,551 sh | 60,551 | $442.0K | <0.01% | -13.2% |
| 7 | BlackRock#7 · 38,591 sh | 38,591 | $281.7K | 0.00% | New |
| 8 | Bridgewater Advisors#8 · 27,326 sh | 27,326 | $241.6K | 0.01% | New |
| 9 | Aaron Wealth Advisors#9 · 32,564 sh | 32,564 | $237.7K | — | New |
| 10 | Tamar Securities#10 · 30,000 sh | 30,000 | $219.0K | 0.02% | 0.0% |
| 11 | ROYAL BANK OF CANADA#11 · 28,250 sh | 28,250 | $206.0K | 0.00% | New |
| 12 | CITADEL ADVISORS#12 · 25,874 sh | 25,874 | $188.9K | 0.00% | New |
| 13 | BROWN BROTHERS HARRIMAN#13 · 23,688 sh | 23,688 | $172.9K | <0.01% | 0.0% |
| 14 | HighTower Advisors#14 · 19,684 sh | 19,684 | $143.7K | <0.01% | 0.0% |
| 15 | RVW Wealth#15 · 18,000 sh | 18,000 | $131.4K | — | 0.0% |
| 16 | GEODE CAPITAL MANAGEMENT#16 · 17,142 sh | 17,142 | $125.1K | 0.00% | 0.0% |
| 17 | LEUCADIA NATIONAL#17 · 16,300 sh | 16,300 | $119.0K | <0.01% | New |
| 18 | Miracle Mile Advisors#18 · 16,000 sh | 16,000 | $116.8K | <0.01% | 0.0% |
| 19 | McCarthy Asset Management#19 · 15,018 sh | 15,018 | $109.6K | — | — |
| 20 | BANK OF AMERICA#20 · 14,124 sh | 14,124 | $103.1K | 0.00% | 0.0% |
| 21 | VANGUARD FIDUCIARY#21 · 12,480 sh | 12,480 | $91.1K | 0.00% | 0.0% |
| 22 | MORGAN STANLEY#22 · 11,347 sh | 11,347 | $82.8K | 0.00% | +13.5% |
| 23 | LPL Financial#23 · 10,300 sh | 10,300 | $75.2K | 0.00% | -22.6% |
| 24 | Cannon Financial Strategists#24 · 10,000 sh | 10,000 | $73.0K | — | New |
| 25 | UBS Group AG#25 · 2,263 sh | 2,263 | $16.5K | 0.00% | +465.8% |
| 26 | Ronald Blue#26 · 1,122 sh | 1,122 | $8.2K | — | 0.0% |
| 27 | WELLS FARGO & COMPANY#27 · 1,000 sh | 1,000 | $7.3K | 0.00% | 0.0% |
| 28 | Pflug Koory#28 · 170 sh | 170 | $1.2K | — | 0.0% |
| 29 | Caitong International Asset Management , Ltd#29 · 31 sh | 31 | $226.00 | 0.00% | New |
Funds that sold out of TTRX in Q2 2026 (2)
Held TTRX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| XTX Topco Ltd19,727 sh | 19,727 | $63.1K |
| Hodges Capital Management10,000 sh | 10,000 | $32.0K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.